1. Home
  2. HOVR vs PYPD Comparison

HOVR vs PYPD Comparison

Compare HOVR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$2.34

Market Cap

80.6M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.72

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
PYPD
Founded
2013
2008
Country
Canada
Israel
Employees
30
75
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.6M
85.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HOVR
PYPD
Price
$2.34
$4.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$10.33
$12.25
AVG Volume (30 Days)
2.0M
59.6K
Earning Date
04-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$2.44
52 Week High
$4.18
$5.12

Technical Indicators

Market Signals
Indicator
HOVR
PYPD
Relative Strength Index (RSI) 54.67 58.47
Support Level $1.70 $4.15
Resistance Level $2.50 $5.05
Average True Range (ATR) 0.29 0.22
MACD -0.02 0.02
Stochastic Oscillator 38.47 87.10

Price Performance

Historical Comparison
HOVR
PYPD

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: